Baxter International Inc.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Baxter International Inc.
Global medtechs had a big enough challenge with COVID-19 and its aftermath before the full-scale regional conflict in Ukraine added more uncertainty to the question of when market normality would return.
When it comes to building innovative pipelines and raising cash, Scandinavia is giving the rest of Europe a run for its money.
Partners Fresenius Kabi and Formycon have submitted a US filing for their FYB202 ustekinumab biosimilar rival to Stelara.
Japan has announced the latest evaluation results under its cost effectiveness assessment scheme. But how does it work and how much have prices been revised so far under the four-year-old program following discussions between pharma firms and authorities?
- Contract Research, Toxicology Testing-CRO
- Medical Devices
- Drug Delivery
- Infusion Therapy Equipment and Supplies
Surgical Equipment & Devices
- Surgical Sealants
- Other Names / Subsidiaries
- AesRX LLC
- Althin Medical A.B.
- Chatham Therapeutics
- Cheetah Medical
- Claris Injectables Limited
- Fusion Medical Technologies, Inc.
- Gambro AB
- Prism Pharmaceuticals, Inc.
- Renal Therapy Services
- SIGMA International Geneeral Medical Apparatus
- SuppreMol GmbH
- Synovis Life Technologies, Inc.
- Wound Care Technologies, Inc.
- Baxter Healthcare Corporation
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.